| Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library HA Parray, AK Chiranjivi, S Asthana, N Yadav, T Shrivastava, S Mani, ... Journal of Biological Chemistry 295 (36), 12814-12821, 2020 | 58 | 2020 |
| Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania A Baranwal, AK Chiranjivi, A Kumar, VK Dubey, P Chandra Scientific reports 8 (1), 8814, 2018 | 39 | 2018 |
| Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus P Murugavelu, R Perween, T Shrivastava, V Singh, HA Parray, S Singh, ... International Immunopharmacology 99, 108020, 2021 | 17 | 2021 |
| Severe acute respiratory syndrome coronavirus 2 spike protein based novel epitopes induce potent immune responses in vivo and inhibit viral replication in vitro P Vishwakarma, N Yadav, ZA Rizvi, NA Khan, AK Chiranjivi, S Mani, ... Frontiers in immunology 12, 613045, 2021 | 17 | 2021 |
| Antioxidant, anti-tyrosinase and anti-inflammatory activities of 3, 5-dihydroxy-4′, 7-dimethoxyflavone isolated from the leaves of Alpinia nigra MK Gupta, S Senthilkumar, AK Chiranjivi, K Banik, S Girisa, ... Phytomedicine Plus 1 (3), 100097, 2021 | 10 | 2021 |
| Dihydrolipoamide dehydrogenase from Leishmania Donovani: new insights through biochemical characterization AK Chiranjivi, VK Dubey International journal of biological macromolecules 112, 1241-1247, 2018 | 8 | 2018 |
| Evaluation of CAAX prenyl protease II of Leishmania donovani as potential drug target: Infectivity and growth of the parasite is significantly lowered after the gene knockout R Bhardwaj, M Das, S Singh, AK Chiranjivi, SV Prabhu, SK Singh, ... European Journal of Pharmaceutical Sciences 102, 156-160, 2017 | 8 | 2017 |
| A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern HA Parray, N Narayanan, S Garg, ZA Rizvi, T Shrivastava, S Kushwaha, ... PLOS Pathogens 18 (12), e1010994, 2022 | 7 | 2022 |
| The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41 R Perween, M PraveenKumar, T Shrivastava, HA Parray, V Singh, ... International Immunopharmacology 101, 108187, 2021 | 7 | 2021 |
| A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometry NK Singh, JA Alonso, JR Devlin, GLJ Keller, GI Gray, AK Chiranjivi, ... Nature Communications 13 (1), 7189, 2022 | 6 | 2022 |
| BLIMP-1 Mediated Downregulation of TAK1 and p53 Molecules Is Crucial in the Pathogenesis of Kala-Azar G Saha, AK Chiranjivi, BM Khamar, K Prerna, M Kumar, VK Dubey Frontiers in Cellular and Infection Microbiology 10, 594431, 2020 | 5 | 2020 |
| Synthesis and characterization of zinc derivatized 3, 5-dihydroxy 4′, 7-dimethoxyflavone and its anti leishmaniasis activity against Leishmania donovani MK Gupta, AK Chiranjivi, T Dutta, VK Dubey, L Rangan Biometals 35 (2), 285-301, 2022 | 3 | 2022 |
| Episomal expression of human glutathione reductase (HuGR) in Leishmania sheds light on evolutionary pressure for unique redox metabolism pathway: Impaired stress tolerance … J Prakash, S Yadav, G Saha, AK Chiranjivi, S Kumar, S Sasidharan, ... International journal of biological macromolecules 121, 498-507, 2019 | 3 | 2019 |
| Biophysical and Biochemical Characterization of the Receptor Binding Domain of SARS-CoV-2 Variants R Khatri, HA Parray, G Siddiqui, AK Chiranjivi, S Raj, R Kaul, V Maithil, ... The Protein Journal 41 (4), 457-467, 2022 | 1 | 2022 |
| Mutational studies on Leishmania donovani dihydrolipoamide dehydrogenase (LdBPK291950. 1) indicates that the enzyme may not be classical class-I pyridine nucleotide-disulfide … AK Chiranjivi, J Prakash, G Saha, P Chandra, VK Dubey International Journal of Biological Macromolecules 164, 2141-2150, 2020 | 1 | 2020 |
| Correction: Kennedy Epitope (KE)-dependent Retrograde Transport of Efficiently Cleaved HIV-1 Envelopes (Envs) and its Effect on Env Cell Surface Expression and Viral Particle … S Das, HA Parray, AK Chiranjivi, P Kumar, A Goswami, M Bansal, ... The Protein Journal, 1-6, 2024 | | 2024 |
| Kennedy epitope (KE)-dependent retrograde transport of efficiently cleaved HIV-1 envelopes (Envs) and its effect on Env cell surface expression and viral particle formation S Das, HA Parray, AK Chiranjivi, P Kumar, A Goswami, M Bansal, ... The Protein Journal, 1-13, 2023 | | 2023 |
| Generation of soluble, cleaved, well-ordered, native-like dimers of dengue virus 4 envelope protein ectodomain (sE) suitable for vaccine immunogen design AK Chiranjivi, D Kumar, R Kumar, HA Parray, S Ahmed, CS Kumar, ... International Journal of Biological Macromolecules 217, 19-26, 2022 | | 2022 |
| Synthesis and evaluation of methyl 4-(7-hydroxy-4, 4, 8-trimethyl-3-oxabicyclo [3.3. 1] nonan-2-yl) benzoate as an antileishmanial agent and its synergistic effect with … PB Prachi Bhalla, SS Sabera Sultana, AK Chiranjivi, AK Saikia, VK Dubey | | 2018 |
| Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania. AB Anupriya Baranwal, AK Chiranjivi, AK Ashutosh Kumar, VK Dubey, ... | | 2018 |
